Study Reveals Importance Of Timing For Cellular Signals, Suggests Possible Tactic For Cancer Therapeutics
Magic tricks work because they take advantage of the brain’s sensory assumptions, tricking audiences into seeing phantoms or overlooking sleights of hand. Now a team of UC San Francisco researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
“The ability to perceive and respond to the environment is a basic attribute of all living organisms, from the greatest to the smallest,” said Wendell Lim, PhD, the study’s senior author. “And so is the susceptibility to misperception. It doesn’t matter if the illusion is based on molecular sensors within a single cell or neurons in the brain.”
In the new study, published online Nov. 19, 2015 in Science Express, Lim and his team discovered that yeast cells falsely perceive a specifically timed pattern of stress – caused by alternating between low and mildly increased sodium levels – as a massive, continuously increasing ramp of stress. In response, the microbes end up over-responding and killing themselves. The results, Lim says, suggest a whole new way of looking at the perceptual abilities of simple cells and could even be used to develop new approaches to fighting diseases using the power of illusion.
Timing of stress response is yeast cells’ ‘Achilles heel’
“This discovery was a bit of an accident actually,” said Lim, chair of the Department of Cellular and Molecular Pharmacology at UCSF, director of the UCSF Center for Systems and Synthetic Biology, and a Howard Hughes Medical Institute (HHMI) investigator. “We were interested in the general issue of how cells interpret information over time. Frequency is a key aspect of all our communications, whether it’s hearing language or transmitting radio signals, but do cells themselves use this kind of information? It’s something we don’t know much about.”
To explore this question, two postdoctoral fellows in Lim’s lab, Ping Wei, PhD, now at Peking University School of Life Sciences, and Amir Mitchell, PhD, set up a system that allowed them to expose yeast to a mild stressor – a small increase in salt in the yeast’s environment – and to oscillate between the increased salt level and the baseline level at different frequencies.
Normally, sensor molecules in a yeast cell detect changes in salt concentration and instruct the cell to respond by producing a protective chemical. After this transient response, the cell can resume growing happily as if conditions had not changed. The researchers found that the cells were perfectly capable of adapting when they flipped the salt stress on and off every minute or every 32 minutes. But to their surprise, when they tried an eight-minute oscillation of precisely the same salt level the cells quickly stopped growing and began to die off.
“That was just a jaw-dropping moment,” said Mitchell. “These cells should be able to handle this level of osmotic stress, but at one particular frequency they just go haywire. We’d never seen anything like this before.”
Could sensory illusions be used to fight cancer?
Mitchell, who was first author on the new study, went on to inspect the cellular mechanism underlying this unexpected, frequency-dependent toxicity. Using mathematical modeling and experiments in which he tweaked the molecular wiring of the mitogen activated protein kinase (MAPK) pathway that mediates the cells’ salt-sensing system, he revealed a sensory misperception: Because of the way the MAPK pathway is set up, the cells interpret an eight-minute oscillation as an ever-increasing staircase of salt concentration. This leads to excessive activation of the cells’ protective response, and ultimately to their death (see Movie).
The Latest on: Cancer Therapeutics
via Google News
The Latest on: Cancer Therapeutics
- Cancer Therapeutics Market Challenges, Key Players, Market Segments, Development, Opportunities, Forecast Report 2026on February 3, 2020 at 10:14 am
New Jersey, United States - The report titled, Cancer Therapeutics Market has been recently published by Verified Market Research. The Cancer Therapeutics market has been garnering remarkable momentum ...
- United Therapeutics’ Unituxin Misses the Mark in Small Cell Lung Cancer Trialon February 3, 2020 at 9:52 am
United Therapeutics, based in Silver Spring, Maryland and Research Triangle Park, North Carolina, announced that its Phase II/III DISTINCT trial failed to meet its primary efficacy endpoint. The trial ...
- Europe Cancer Therapeutics Market Report 2020 to 2025 - Growth, Trends, and Forecast - ResearchAndMarkets.comon February 3, 2020 at 9:13 am
DUBLIN--(BUSINESS WIRE)--The "Europe Cancer Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. This report covers several big ...
- Anal Cancer Therapeutics Market 2019 Analysis and Precise Outlook – GlaxoSmithKline Pharmaceuticals, Spectrum Pharmaceuticalson February 3, 2020 at 8:21 am
The report titled "Anal Cancer Therapeutics Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries ...
- United Therapeutics gets disappointing news on cancer therapyon February 3, 2020 at 8:02 am
United Therapeutics studied one of its cancer therapies, Unituxin, in a different form of cancer. But it didn’t achieve the results the company was looking for.
- United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trialon February 3, 2020 at 7:11 am
An effort to expand use of a United Therapeutics oncology drug to the treatment of small cell lung cancer has fallen short. United Therapeutics (NASDAQ: UTHR) announced Monday that a Phase 2/3 study ...
- Spain Cancer Diagnostics Market, 2020 – Abbott, Beckman Coulter, Exact Sciences, Guided Therapeutics & Vermillion – ResearchAndMarkets.comon February 3, 2020 at 6:16 am
The “2020 Spain Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation” report has been added to ...
- Global Pancreatic Cancer Therapeutics and Diagnostics Market Latest Trends, Growth, Opportunities and Forecast 2028on February 3, 2020 at 5:54 am
Total Healthcare Spending around the Globe was USD 7.5 Trillion in 2016 - W.H.O. CRIFAX added a report on 'Global Pancreatic Cancer Therapeutics and Diagnostics Market, 2020-2028'to its database of ...
- Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Programon February 3, 2020 at 5:30 am
FABP5 platform under exclusive license to Artelo Biosciences NCI support provides further validation of next-generation target for cancer therapeutics ...
- UK Cancer Diagnostics Market, 2020 - Abbott, Beckton Dickinson, Guided Therapeutics, Roche & Wako Pure Chemicals - ResearchAndMarkets.comon February 3, 2020 at 5:07 am
DUBLIN--(BUSINESS WIRE)--The "2020 UK Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation" ...
via Bing News